← Leaderboards
Patrick McGorry
Orygen Youth Health Research Centre
$6,003,078
Attributed
$6,003,078
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.8M · FY2015–19$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$6,003,078 · 1
By mechanism
U01$6,003,078 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Antidepressive Agents”
- Gregory N Clarke · Kaiser Foundation Research Institute$16,157,794
- Warren D Taylor · Vanderbilt University Medical Center$15,863,045
- Eric J Nestler · Icahn School Of Medicine At Mount Sinai$12,352,061
- E Sherwood Brown · Ut Southwestern Medical Center$11,733,289
- Yvette I Sheline · University Of Pennsylvania$11,556,201
- Katherine L Narr · University Of California Los Angeles$11,098,433
Research focus
Antidepressive AgentsAntipsychotic AgentsAspirinAustraliaBehavioralBiologicalBiological MarkersCare SystemsCaringCase ManagementCessation Of LifeClinicClinical InfrastructureClinical PhenotypeClinical TreatmentClinical TrialsCognitiveCohortCollaborationsDesignDisabilityDisorder Later Incidence PreventionDistressAdministrator
Grant awards (5)
Building the Evidence Base for Adaptive Treatment Sequences in Clinical High Risk$602,843
U01 · FY2019 · MH · contact PI
Building the Evidence Base for Adaptive Treatment Sequences in Clinical High Risk$1,123,236
U01 · FY2018 · MH · contact PI
Building the Evidence Base for Adaptive Treatment Sequences in Clinical High Risk$1,758,066
U01 · FY2017 · MH · contact PI
Building the Evidence Base for Adaptive Treatment Sequences in Clinical High Risk$1,616,896
U01 · FY2016 · MH · contact PI
Building the Evidence Base for Adaptive Treatment Sequences in Clinical High Risk$902,037
U01 · FY2015 · MH · contact PI